Innovative Vaginal Speculum Design Aims to Reduce Fear and Discomfort During Gynecological Exams

A team of researchers has redesigned the traditional vaginal speculum to make gynecological exams more comfortable, less intimidating, and less painful, potentially improving women's healthcare experiences.
Recently, researchers at Delft University in the Netherlands have embarked on a project to transform the traditional vaginal speculum— a common yet often distressing tool used in gynecological examinations. The conventional speculum, typically made of cold, rigid metal, has long been associated with discomfort, anxiety, and even pain for many patients, partly due to its intimidating appearance and the discomfort caused during insertion and examination.
Tamara Hoveling, a Ph.D. candidate with substantial experience working with the speculum, expressed her concerns about the device's design. She reflected on the dark history of the instrument, originally developed over 180 years ago by Dr. James Marion Sims in the United States, who tested it on enslaved women without consent. Motivated by the need for a more respectful and comfortable approach, Hoveling collaborated with industrial design master's student Ariadna Izcara Gual to rethink the device.
The pair identified that the existing Cusco speculum's metal structure could cause significant discomfort and anxiety, as muscles tend to tense up when patients are scared, making the insertion and manipulation more painful. Their goal was to develop a more patient-friendly alternative inspired by natural forms that open and accommodate the reproductive organs more gently.
The result was the creation of the "Lilium," a prototype named after the lily flower. Unlike traditional models, Lilium features soft plastic materials and a design that resembles a tampon with an applicator, focusing on patient comfort and ease of use. Its three-sided opening prevents collapse of the vaginal walls, providing better visibility for healthcare providers during examinations. This innovative design positions the patient at the forefront, aiming to reduce fear and improve the overall experience.
Though still in the early stages, the Lilium prototype has undergone initial ergonomic testing and material research. The researchers are working towards securing safety certifications, conducting human trials, and obtaining regulatory approval, with the ultimate aim of bringing the device into clinical use.
The project has garnered rapid support; a crowdfunding campaign quickly raised over 100,000 euros within two days, highlighting the strong public demand for improvements in gynecological care. Many women have shared that fear of the speculum discourages them from seeking regular gynecological screenings, which are vital for early detection of conditions like cervical cancer—a leading health concern globally.
With sufficient funding, the researchers believe the Lilium could be available within five years, potentially transforming women's health experiences and encouraging more regular healthcare visits.
Source: https://medicalxpress.com/news/2025-07-redesign-vaginal-speculum-ease-pain.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Radiologists assess response to large-scale terror attack and mass casualties
A new study highlights how radiology departments in Israel managed the massive influx of patients during the 2023 terror attack, emphasizing flexible protocols, AI tools, and staff resilience to improve crisis response and patient outcomes.
Research Finds Hepatitis B Immunity May Reduce Diabetes Risk
A new study reveals that immunity to hepatitis B virus, achieved through vaccination, may decrease the risk of developing diabetes, especially among younger adults. This discovery suggests additional health benefits of HBV vaccination beyond infection prevention.
Breakthrough in Chagas Disease: Antibodies Show Promising Potential for Vaccine Development
Innovative research uncovers highly effective neutralizing antibodies against Trypanosoma cruzi, paving the way for vaccine development to combat Chagas disease—one of the world's most neglected tropical illnesses.
New Cholesterol-Lowering Drug Shows Promise for High-Risk Heart Patients
A new cholesterol-lowering medication, Obicetrapib, shows promising results in reducing LDL cholesterol and Lp(a) levels in high-risk cardiovascular patients, potentially offering a new treatment option to prevent heart attacks and strokes.



